The reiMMAgine Study: Evaluation of the Safety, Tolerability, and Pharmacodynamics of AAV8 Gene Therapy (MMA-101) in Combination with an Immunotolerance-Inducing Nanoparticle (ImmTOR) in MUT Subtype Isolated Methylmalonic Acidemia (MMA)

MOLECULAR THERAPY(2023)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要